{
  "docId": "019dd923-5e88-73ef-bd5a-d62c891ad637",
  "docSlug": "d07ec288d5b21a01",
  "documentTitle": "2025 JP Morgan Healthcare Conference",
  "authorId": "JPMorgan",
  "authorName": "P&A Global",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "equity_research",
  "sourceTypeLabel": "Equity research",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.773,
  "pageNumber": 2,
  "pageCount": 3,
  "prevPage": 1,
  "nextPage": 3,
  "slideType": "initiative_list",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "This is a continuation of a list (starts at item 7).",
  "elementsJson": [
    "numbered_list",
    "logo_grid"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5a-d62c891ad637/2",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5a-d62c891ad637",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5a-d62c891ad637.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-d62c891ad637#slide-2",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.17,
        "x": 0.03,
        "y": 0.02
      },
      "kind": "image",
      "text": "P&A Global",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4074f520-108a-4682-bbe5-5a994d475752",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.68,
        "x": 0.16,
        "y": 0.15
      },
      "kind": "list",
      "text": "7. Pfizer: Reaffirmed revenue targets and highlighted the impact of the Inflation Reduction Act. The company plans to focus on oncology growth through its acquisition of Seagen and expects regulatory decisions for key products in 2025.\n8. Sarepta Therapeutics: Reported strong revenue growth driven by ELEVIDYS and outlined plans for expanding its gene therapy and RNA-based platforms. The company aims for significant revenue growth and multiple data readouts in 2025.\n9. Teva Pharmaceutical: Highlighted consecutive revenue growth and its Pivot to Growth strategy. The company focuses on innovative medicines and biosimilars, with key drugs like Austedo and Ajovy showing significant growth.\n10. Vertex Pharmaceuticals: Focused on the approval of Alyftrek for cystic fibrosis and the development of suzetrigine for acute pain. The company plans to expand its renal franchise and manufacturing capacity for Casgevy.\n11. Ascendis Pharma: Emphasized rapid revenue growth and the success of Skytrofa and Yorvipaith. The company plans to expand its endocrinology portfolio and form significant partnerships.\n12. BridgeBio Pharma: Highlighted clinical progress and the commercial potential of Attruby for ATTR-CM. The company expects pivotal data readouts and regulatory submissions in 2025.\n13. Cytokinetics: Focused on the launch of aficamten and omecamtiv mecarbil for heart failure. The company aims to build relationships with payers and achieve market access for its products.\n14. Edgewise Therapeutics: Reported progress in its muscle disease and cardiovascular disease pipeline. The company anticipates multiple data readouts and regulatory submissions in 2025.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f0d0fda4-e938-41ca-b0c3-81b7313b7885",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "9e2dbbb9-2e02-443b-bf10-3a96fc59a946",
      "evidence": "list/bullet: 7. Pfizer: Reaffirmed revenue targets and highlighted the impact of the Inflation Reduction Act.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 3,
      "from": 2,
      "beatId": "99ad4a1b-6a50-4fae-935e-79e6d5c324e1",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "The initiative lists provide evidence of industry updates and developments.",
      "position": 1,
      "confidence": 0.7,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}